The Business
Research Company published its Cervical Cancer Diagnostics Global Market Report
2020 which provides strategists, marketers and senior management with the
critical information they need to assess the global Cervical Cancer Diagnostics
market. The report provides in-depth analysis of the impact of COVID-19 on the
market, along with revised market numbers due to the effects of the
coronavirus.
The report covers the Cervical Cancer
Diagnostics market’s segments-
1) By
Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical
Curettage, Other Diagnostic Tests
2) By End
User: Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers,
Diagnostic Centers
View Complete Report:
Cervical Cancer Diagnostics Global Market Report 2020 is the
most comprehensive report available on this market and will help gain a truly
global perspective as it covers 60 geographies. The chapter on the impact of
COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
The global cervical cancer diagnostics market is expected to
decline from $8.02 billion in 2019 to $7.23 billion in 2020 at a compound
annual growth rate (CAGR) of -9.87%. The decline is mainly due to the COVID-19
outbreak that has led to restrictive containment measures involving social
distancing, especially postponement of non-emergency procedures. The market is
then expected to recover and reach $8.62 billion in 2023 at a CAGR of 6.04%.
The increased adoption of HPV home testing kits is expected
to be the new trend in the market. The home-based HPV testing kits help women
in collecting samples and getting the results conveniently on their own without
going to the lab for screening. Therefore, companies are focusing on providing
convenience to patients.
Few Points From Table Of Content
1. Executive
Summary
2. Cervical
Cancer Diagnostics Market Characteristics
3. Cervical
Cancer Diagnostics Market Size And Growth
4. Cervical
Cancer Diagnostics Market Segmentation
5. Cervical
Cancer Diagnostics Market Regional And Country Analysis
......
25. Cervical
Cancer Diagnostics Market Competitive Landscape And Company Profiles
26. Key
Mergers And Acquisitions In The Cervical Cancer Diagnostics Market
27. Cervical
Cancer Diagnostics Market Trends And Strategies
28. Cervical
Cancer Diagnostics Market Future Outlook and Potential Analysis
29. Appendix
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3285&type=smp
Few Points From List
Of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F,
2025F, 2030F, $ Billion
Table 3: Global Cervical Cancer Diagnostics Market,
Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F,
2025F, 2030F, $ Billion
Table 4: Global Cervical Cancer Diagnostics Market,
Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F,
2030F, $ Billion
………
Table 27: Becton, Dickinson and Co. Financial Performance
Table 28: Bio-Rad Laboratories Inc. Financial Performance
Table 29: F. Hoffmann-La Roche Ltd. Financial Performance
Table 30: Hologic Inc. Financial Performance
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
